- Both cyclobenzaprine (Flexeril) and methocarbamol (Robaxin) are prescription, centrally acting muscle relaxants used short-term for acute musculoskeletal pain — they are prescriber-directed, not self-dosed.
- Cyclobenzaprine is more sedating and has notable anticholinergic effects; it is on the AGS Beers Criteria list of medications to generally avoid in older adults and carries serotonin-syndrome cautions with certain drugs.
- Methocarbamol is generally less sedating and has fewer interactions, but MedlinePlus notes older adults usually should not take it either; it can harmlessly discolor urine.
- Dose ranges quoted here are label reference points, not a schedule to follow on your own — your prescriber sets the actual dose, strength, and duration (typically only a few weeks).
- Never combine either drug with alcohol, opioids, benzodiazepines, or other CNS depressants; the FDA warns this can cause dangerous sedation and slowed breathing. Severe allergic reactions or trouble breathing are a 911 emergency.
- How Each Medication Works
- Comparison Table
- Effectiveness for Muscle Spasms
- Side Effects: The Critical Difference
- Cyclobenzaprine Side Effects
- Methocarbamol Side Effects
- Which Patients Might Suit Each Medication
- Non-Drug Alternatives to Consider
- Frequently Asked Questions
- Can I take cyclobenzaprine and methocarbamol together?
- Which muscle relaxant is less sedating?
- Are muscle relaxants addictive?
- Can I drink alcohol while taking muscle relaxants?
- The Bottom Line
- Related guides
- Sources
Muscle spasms from acute injuries or chronic conditions send millions of Americans to the doctor each year, and the cyclobenzaprine vs methocarbamol question is one of the more common medication comparisons in musculoskeletal care. Both are prescription, centrally acting muscle relaxants used for short-term relief of acute musculoskeletal pain, but they differ in how sedating they are, how they behave in the body, and which situations they tend to suit. Cyclobenzaprine (Flexeril) is structurally related to tricyclic antidepressants and acts centrally, while methocarbamol (Robaxin) works through a less well-understood central mechanism and is usually less sedating. This article is general education, not medical advice — which drug (if any) is right for you is a decision for your prescriber.
According to the CDC, low back pain is among the leading reasons for missed workdays in the United States. If you are dealing with muscle spasms and want to understand how these two options differ, this comparison from our medical conditions guide can help you have a more informed conversation with your clinician.
How Each Medication Works
Cyclobenzaprine (Flexeril, Amrix) acts primarily in the brainstem, reducing motor-neuron activity and the nerve signals that drive muscle spasm; it does not act directly on the muscle fiber itself. Its chemical structure closely resembles amitriptyline, a tricyclic antidepressant, which explains many of its side effects. MedlinePlus describes it as working in the brain and nervous system to let muscles relax, and it is one of the most-studied centrally acting muscle relaxants.
Methocarbamol (Robaxin) also acts centrally, but its precise mechanism is not fully understood. It is thought to reduce the perception of muscle spasm through general central-nervous-system depression rather than by targeting a specific nerve pathway. Methocarbamol is generally considered a milder agent with less pronounced sedation than cyclobenzaprine, which is why some clinicians favor it for people who need to stay functional during treatment.
Comparison Table
The dose figures below are label reference ranges drawn from the FDA prescribing information, included for context only. They are not a schedule to follow on your own; your prescriber sets the actual strength, dose, and duration based on your situation.
| Feature | Cyclobenzaprine (Flexeril) | Methocarbamol (Robaxin) |
|---|---|---|
| Drug Class | Centrally acting muscle relaxant | Centrally acting muscle relaxant |
| Prescription Status (US) | Prescription only | Prescription only |
| Available Strengths | 5 mg, 7.5 mg, 10 mg tablets; extended-release 15 mg, 30 mg capsules | 500 mg, 750 mg tablets |
| Label Dose Range (reference only) | Immediate-release commonly labeled 5 mg to 10 mg three times daily | Commonly labeled around 750 mg to 1,500 mg, taken several times daily |
| Sedation Level | Higher | Lower to moderate |
| Recommended Duration | Short-term (label: generally not more than 2-3 weeks) | Short-term (prescriber-directed) |
| Half-Life | Long (roughly 18-33 hours) | Short (roughly 1-2 hours) |
| Anticholinergic Effects | Significant | Minimal |
| Older Adults | On AGS Beers list — generally avoid | MedlinePlus: older adults usually should not use |
| Notable Interactions | MAOIs, serotonergic drugs; CNS depressants | Fewer, but still CNS depressants |
| Typical Generic Cost | Low (often a few dollars to ~$15/month; varies) | Low (often ~$10-$25/month; varies) |
Effectiveness for Muscle Spasms
Both medications are used for acute musculoskeletal conditions, but rigorous head-to-head data is limited. A Cochrane systematic review found that muscle relaxants as a class provide modest benefit for acute low back pain, with cyclobenzaprine being among the most-studied options. Muscle relaxants are generally most useful as a short-term add-on rather than a standalone cure.
Cyclobenzaprine has more published clinical-trial data. Multiple studies show it reduces muscle-spasm severity and improves function versus placebo, particularly alongside an NSAID such as ibuprofen. Its strong sedative effect — a drawback during the day — can help when spasms disrupt sleep, which is one reason some clinicians dose it at bedtime.
Methocarbamol has fewer rigorous trials but decades of clinical use behind it. Many clinicians prefer it for people who need to work, drive, or stay alert during treatment. Studies have found it comparable to other muscle relaxants for acute back pain with fewer sedation-related complaints. The better choice depends on the individual, which is why it is a prescriber’s call rather than a fixed rule.
Side Effects: The Critical Difference
The side-effect profile is often the deciding factor in the cyclobenzaprine vs methocarbamol choice. Cyclobenzaprine’s tricyclic-like structure gives it a broader, more pronounced burden.
Cyclobenzaprine Side Effects
Drowsiness is the most common effect and can be substantial. Dry mouth, dizziness, constipation, blurred vision, and urinary retention reflect its anticholinergic activity. Because of its long half-life, sedation can carry into the next day. MedlinePlus also warns of a rare but serious serotonin-syndrome-like reaction — agitation, fever, sweating, confusion, fast or irregular heartbeat, and severe muscle stiffness — especially when combined with certain other drugs, and it should not be used within two weeks of an MAOI. For a fuller breakdown, see our article on cyclobenzaprine side effects.
Cyclobenzaprine is generally best avoided in older adults because its anticholinergic and sedating properties raise the risk of falls, confusion, and urinary retention. The 2023 American Geriatrics Society (AGS) Beers Criteria lists skeletal muscle relaxants, including cyclobenzaprine, among medications that are potentially inappropriate for older adults.
Methocarbamol Side Effects
Drowsiness and dizziness are the most common effects but tend to be milder than with cyclobenzaprine. Nausea, headache, upset stomach, blurred vision, and lightheadedness can also occur. Methocarbamol can cause a harmless black, blue, or green discoloration of the urine, which can alarm people who were not warned about it. It is generally better tolerated, though MedlinePlus notes that older adults usually should not take it either, since safer or more effective options often exist for them.
When to seek emergency care: Call 911 or go to the nearest emergency room for signs of a severe allergic reaction (hives, swelling of the face, lips, tongue, or throat, or trouble breathing), seizures, a very slow heartbeat, fainting, or symptoms of serotonin syndrome (high fever, severe agitation, muscle rigidity) after taking either medication.
Which Patients Might Suit Each Medication
Cyclobenzaprine may be considered for: people with severe spasms that disrupt sleep, younger adults without anticholinergic sensitivity, and short courses for acute injuries — with the sedation sometimes leveraged for nighttime dosing. These are clinical judgments a prescriber makes, not choices to self-direct.
Methocarbamol may be considered for: people who need to work or drive during treatment, those taking several other medications (fewer interactions), and people with conditions such as glaucoma or urinary retention where a lower anticholinergic burden matters. Again, the prescriber weighs age, other drugs, and health conditions.
Neither medication should be combined with alcohol, benzodiazepines, opioids, or other central-nervous-system depressants. According to the FDA, combining CNS depressants can cause profound sedation, dangerously slowed breathing, and death.
Non-Drug Alternatives to Consider
Muscle relaxants work best as part of a broader plan rather than on their own. Physical therapy, gentle stretching and gradual movement, heat and ice, and over-the-counter pain relievers (used per label) are important complements. Many clinicians limit muscle relaxants to the first week or two of an acute injury and then transition to physical therapy and self-care for ongoing recovery.
If your spasms are tied to a specific injury, recovery timelines vary. For related reading, see our guides on how to treat a sprained ankle and shoulder surgery recovery.
Frequently Asked Questions
Can I take cyclobenzaprine and methocarbamol together?
Not without a prescriber’s direction. Combining two muscle relaxants meaningfully increases the risk of excessive sedation, dizziness, and impaired coordination. If one is not helping enough, a clinician may switch agents or add a complementary treatment such as physical therapy or an NSAID rather than stacking two relaxants.
Which muscle relaxant is less sedating?
Methocarbamol is generally less sedating than cyclobenzaprine, so it is often preferred when daytime drowsiness is the main concern. Individual responses vary, though, and only your prescriber can weigh this against your other medications and health conditions.
Are muscle relaxants addictive?
Neither cyclobenzaprine nor methocarbamol is a DEA-scheduled controlled substance, and physical dependence is uncommon with short-term use. Even so, some people misuse them for sedation, and both are intended for short courses (commonly a few weeks). Follow your prescriber’s plan and do not extend use on your own.
Can I drink alcohol while taking muscle relaxants?
No. Both drugs amplify the effects of alcohol, which can cause dangerous drowsiness, impaired coordination, slowed breathing, and loss of consciousness. Avoid alcohol entirely while taking either medication, and avoid other CNS depressants unless your prescriber has specifically approved them.
The Bottom Line
The cyclobenzaprine vs methocarbamol decision comes down to a tradeoff between potency and tolerability. Cyclobenzaprine is the more potent option with more clinical evidence, but its sedation and anticholinergic effects limit day-to-day use and make it a poor fit for older adults. Methocarbamol offers a gentler profile that lets many people stay active while managing spasms, though it is not risk-free either. Both are prescriber-directed, short-term tools.
For most acute back pain and muscle-spasm situations, either medication combined with ice, gentle movement, and appropriate over-the-counter pain relievers can bring meaningful relief within a few days. Talk with your doctor or pharmacist about which option — if any — best matches your age, other medicines, and daily demands. Muscle relaxants are a short-term aid; addressing the underlying cause through physical therapy and gradual reconditioning is what supports lasting recovery.
This article is general education and is not medical advice. Cyclobenzaprine and methocarbamol are prescription medications; the dose ranges mentioned are label reference points for context, not instructions to self-dose, self-titrate, or follow a schedule. Only a qualified clinician can decide whether either drug is appropriate for you and set the strength, dose, and duration. Do not combine these medications with alcohol, opioids, benzodiazepines, or other CNS depressants unless your prescriber directs it. For a severe allergic reaction, seizures, or trouble breathing, call 911; for a suspected overdose, call Poison Control at 1-800-222-1222.
Sources
- MedlinePlus (U.S. National Library of Medicine) — Cyclobenzaprine and Methocarbamol drug information
- DailyMed (NIH) — FDA prescribing information (labels) for cyclobenzaprine and methocarbamol
- American Geriatrics Society (AGS) — 2023 AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
- U.S. Food and Drug Administration (FDA) — warnings on combining CNS depressants
- CDC / National Center for Health Statistics (NCHS) — burden of low back pain
